Oxidative stress effect of dopamine on α-synuclein: Electroanalysis of solvent interactions

ACS Chemical Neuroscience

Volumn 3, Issue 7, 2012, Pages 569-574

  Chan, Tiffiny ^a   Chow, Ari M ^a   Cheng, Xin R ^a   Tang, Derek W F ^a   Brown, Ian R ^a   Kerman, Kagan ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

synuclein; aggregation; Dopamine; electroanalysis; Parkinsons disease; tyrosine

Indexed keywords

ALPHA SYNUCLEIN; DOPAMINE; OLIGOMER; SOLVENT; TYROSINE;

ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ELECTROCHEMICAL ANALYSIS; IONIC STRENGTH; OXIDATION; OXIDATIVE STRESS; PH; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN INTERACTION; PROTEIN STABILITY; PROTEIN STRUCTURE;

ALPHA-SYNUCLEIN; DOPAMINE; ELECTROCHEMISTRY; OXIDATIVE STRESS; SOLVENTS;

EID: 84863901371     PISSN: None     EISSN: 19487193     Source Type: Journal    
DOI: 10.1021/cn300034t     Document Type: Article

References (42)

1. Erickson, J., Wszolek, Z., and Petrucelli, L. (2005) Molecular pathogoenesis of Parkinson disease Arch. Neurol. 62, 353-357
2. Kruger, R., Kuhn, W., Muller, T., Woitalla, D., Graeber, M., Kosel, S., Przuntek, H., Epplen, J. T., Schols, L., and Riess, O. (1998) Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinsons disease Nat. Genet. 18, 106-108
3. Dauer, W. and Przedborski, S. (2003) Parkinsons Disease: Mechanisms and models Neurology 39, 889-909
4. Polymeropoulos, M., Lavedan, C., Leroy, E., Ide, S., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., Stenroos, E. S., Chandrasekharappa, S., Athanassiadou, A., Papapetropoulos, T., Johnson, W. G., Lazzarini, A. M., Duvoisin, R. C., Di Iorio, G., Golbe, L. I., and Nussbaum., R. L. (1997) Mutation in the α-synuclein gene identified in families with Parkinsons disease Science 276, 2045-2047 (Pubitemid 27443610)
5. Conway, K., Lee, S.-J., Rochet, J.-C., Ding, T., Williamson, R., and Lansbury, P., Jr. (2000) Acceleration of oligomerization, not fibrillization is a shared property of both α-synuclein mutations linked to early-onset Parkinsons disease: Implications for pathogensis and therapy Proc. Natl. Acad. Sci. U.S.A. 97, 571-576 (Pubitemid 30070350)
6. Waxman, E. and Giasson, B. (2009) Molecular mechanisms of α-synuclein neurodegeneration Biochim. Biophys. Acta 1792, 616-624
7. Iwata, A., Maruyama, M., Kanazawa, I., and Nukina, N. (2001) α-synuclein affects the MAPK pathway and accelerates cell death J. Biol. Chem. 276, 45320-45329
8. Jenco, J., Rawlingson, A., Daniels, B., and Morris, A. (1998) Regulation of phospholipase D2: selective inhibition of mammalian phospholipase D isoenzymes by α- and β- synucleins Biochemistry 37, 4901-4909 (Pubitemid 28175972)
9. Lotharius, J. and Brundin, P. (2002) Pathogenesis of Parkinsons disease: Dopamine, vesicles and α-synuclein Nat. Rev. Neurosci. 3, 932-942
10. Sharon, R., Bar-Josef, I., Betenski, R., Shen, J., and Selkoe, D. (2001) α-Synuclein occurs in lipid-rich molecular weight complexes, binds fatty acids, and shows homology to the fatty acid-binding proteins Proc. Natl. Acad. Sci. U.S.A. 98, 9110-9115 (Pubitemid 32743877)
11. Davidson, W., Jonas, A., Clayton, D., and George, J. (1998) Stabilization of α-synuclein secondary structure upon binding to synthetic membranes J. Biol. Chem. 98, 9443-9449 (Pubitemid 28183026)
12. Sharon, R., Bar-Josef, I., Frosch, M., Walsh, D., Hamilton, J., and Selkoe, D. (2003) The formation of highly soluble oligomers of α-synuclein is regulated by fatty acids and enhanced in Parkinsons disease Neuron 37, 583-595 (Pubitemid 36262981)
13. McLean, P., Kawamata, H., Ribich, S., and Hyman, B. (2000) Membrane association and protein conformation of α-synuclein in intact neurons J. Biol. Chem. 275, 8812-8816
14. Halliwell, B. and Gutteridge, J. (1985) Oxygen radicals and the nervous system Trends Neurosci. 8, 22-26 (Pubitemid 15171404)
15. Latawiec, D., Herrera, F., Bek, A., Losasso, V., Candotti, M., Benetti, F., Carlino, E., Kranjc, A., Lazzarino, M., Gustincich, S., Carloni, P., and Legname, G. (2010) Modulation of alpha-synuclein aggregation by dopamine analogs PLOS One 5, 9234
16. Zhu, M., Rajamani, S., Kaylor, J., Han, S., Zhou, F., and Fink, A. (2004) The flavonoid baicalein inhibits fibrillation of α-synuclein and disaggregates existing fibrls J. Biol. Chem. 279, 26846-26857 (Pubitemid 38812518)
17. Conway, K., Harper, J., and Lansbury, P. (1998) Accelerated in vitro fibril formation by a mutant α-synuclein linked to early-onset Parkinsons disease Nature 4, 1318-1320 (Pubitemid 28512115)
18. Mazzulli, J., Mishizen, A., Giasson, B., Lynch, D., Thomas, S., Nakashima, A., Nagatsu, T., Ota, A., and Ischiropoulos, H. (2006) Cytosolic catechols inhibit α-synuclein aggregation and facilitates the formation of intracellular soluble oligomeric intermediates J. Neurosci. 26, 10068-10078 (Pubitemid 44477168)
19. Pham, C., Leong, S., Ali, F., Kenche, V., Hill, A., Gras, S., Barnham, K. J., and Cappai, R. (2009) Dopamine and the dopamine oxidation product 5,6-dihyroxylindole promote distinct on-pathway and off-pathway aggregation of α-synuclein in a pH-dependent manner J. Mol. Biol. 387, 771-785
20. Xu, J., Kao, S.-Y., Lee, F., Song, W., Jin, L.-W., and Yanker, B. (2002) Dopamine-dependent neurotoxicity of α-synuclein: A mechanism for selective neurodegeneration in Parkinsons disease Nat. Med. 8, 600-606 (Pubitemid 34633438)
21. Hattori, N., Wang, M., Taka, H., Fujimura, T., Yoritaka, A., Kubo, S., and Mochizuki, H. (2009) Toxic effects of dopamine metabolism in Parkinsons disease Parkinsonism Relat. Disord. 15, S35-S38
22. Leong, S., Pham, C., Galatis, D., Fodero-Tavoletti, M., Perez, K., Hill, A. F., Masters, C. L., Ali, F. E., Barnham, K. J., and Cappai, R. (2009) Formation of dopamine-mediated α-synuclein-soluble oligomers requires methionine oxidation Free Radical Biol. Med. 46, 1328-1337
23. Masarik, M., Stobiecka, A., Kizek, R., Jelen, F., Pechan, Z., Hoyer, W., Jovin, T. M., Subramaniam, V., and Palecek, E. (2004) Sensitive electrochemical detection of native and aggregated α-synuclein protein involved in Parkinsons disease Electroanalysis 16, 1172-1181
24. Palecek, E., Ostana, V., Masarik, M., Bertoncini, C., and Jovin, T. M. (2008) Changes in interfacial properties of α-synuclein preceding its aggregation Analyst 133, 76-84 (Pubitemid 350265602)
25. Chan, T., Chow, A., Tang, D., Li, Q., Wang, S., Brown, I., and Kerman, K. (2010) Interaction of baicalein and copper with alpha-synuclein: Electrochemical approach to the Parkinsons disease J. Electroanal. Chem. 648, 151-155
26. Brabec, V. and Schindlerova, I. (1981) Electrochemical behaviour of proteins at graphite electrodes Part III. The effect of protein adsorption Bioelectrochem. Bioenerg. 8, 451-458
27. Reynaud, J., Malfoy, B., and Bere, A. (1980) The electrochemical oxidation of three proteins: RNAase A, bovine serum albumin and concanavalin A at solid electrodes J. Electroanal. Chem. 116, 595-606
28. Cai, X., Rivas, G., Farias, P., Shiraishi, H., Wang, J., and Palecek, E. (1996) Potentiometric stripping analysis of bioactive peptides at carbon electrodes down to subnanomolar concentrations Anal. Chim. Acta 332, 49-57 (Pubitemid 26352717)
29. MacDonald, S. and Roscoe, S. (1997) Electrochemical oxidation reactions of tyrosine, tryptophan and related dipeptides Electrochim. Acta 42, 1189-1200 (Pubitemid 127411855)
30. Brabec, V. and Mornstein, V. (1980) Electrochemical behaviour of proteins at graphite electrodes II. Electrooxidation of amino acids Bioelectrochem. Bioenerg. 12, 159-165
31. Vestergaard, M., Kerman, K., Saito, M., Nagatani, N., Takamura, Y., and Tamiya, E. (2005) A rapid label-free electrochemical detection and kinetic study of Alzheimers amyloid beta aggregation J. Am. Chem. Soc. 127, 11892-11893 (Pubitemid 41233687)
32. Chikae, M., Fukuda, T., Kerman, K., Idegami, K., Miura, Y., and Tamiya, E. (2008) Amyloid-beta detection with saccharide immobilized gold nanoparticle on carbon electrode Bioelectrochemistry 74, 118-123
33. Veloso, A. J., Hung, V. W. S., Sindhu, G., Constantinof, A., and Kerman, K. (2009) Electrochemical oxidation of benzothiazole dyes for monitoring amyloid formation related to the Alzheimers disease Anal. Chem. 81, 9410-9415
34. Veloso, A. J., Yoshikawa, H., Cheng, X. R., Tamiya, E., and Kerman, K. (2011) Optical trapping for the characterization of amyloid-beta aggregation kinetics Analyst 136, 4164-4167
35. Keithley, R. B. and Wightman, R. M. (2011) Assessing principal component regression prediction of neurochemicals detected with fast-scan cyclic voltammetry ACS Chem. Neurosci. 2, 514-525
36. Keithley, R. B., Takmakov, P., Bucher, E. S., Belle, A. M., Owesson-White, C. A., Park, J., and Wightman, R. M. (2011) Higher sensitivity dopamine measurements with faster-scan cyclic voltammetry Anal. Chem. 83, 3563-3571
37. Hermans, A., Keithley, R. B., Kita, J. M., Sombers, L. A., and Wightman, R. M. (2008) Dopamine detection with fast-scan cyclic voltammetry used with analog background subtraction Anal. Chem. 80, 4040-4048 (Pubitemid 351812754)
38. Venton, B. J. and Wightman, R. M. (2003) Psychoanalytical electrochemistry: Dopamine and behaviour Anal. Chem. 75, 414A-421A
39. DuVall, S. and McCreery, R. (2000) Self-catalysis by chatechols and quinones during heterogeneous electron transfer at carbon electrodes J. Am. Chem. Soc. 122, 6759-6764 (Pubitemid 30489998)
40. Cappai, R., Leck, S.-L., Tew, D., Williamson, N., Smith, D., Galatis, D., Sharples, R. A., Curtain, C. C., Ali, F. E., Cherny, R. A., Culvenor, J. G., Bottomley, S. P., Masters, C. L., Barnham, K. J., and Hill, A. F. (2005) Dopamine promotes α-synuclein aggregation into SDS-resistant soluble oligomers via a distinct folding pathway FASEB J. 19, 1377-1379 (Pubitemid 41113755)
41. Rekas, A., Knott, R., Sokolova, A., Barnham, K., Perez, K., Masters, C., Drew, S. C., Cappai, R., Curtain, C. C., and Pham, C. L. (2010) The structure of dopamine induced α-synuclein oligomers Eur. Biophys. J. 39, 1407-1419
42. Hoyer, W., Antony, T., Cherny, D., Heim, G., Jovin, T., and Subramaniam, V. (2002) Dependence of α-synuclein aggregate morphology on solution conditions J. Mol. Biol. 322, 383-393